Ep. 50: mRNA vaccines in India ft. Soham Sankaran
Aug 21, 2023•1 hr 2 min
Listen to this episode in Metacast mobile app
Don't just listen to podcasts. Learn from them with transcripts, summaries, and chapters for every episode. Skim, search, and bookmark insights. Learn more
Episode description
I spoke to Soham Sankaran who runs PopVax, an Indian mRNA vaccine company. Their goal is to build low-cost broadly-protective vaccines to protect against the entire sarbecovirus species. Read Soham's experience here (https://chronicles.popvax.com/p/three-meetings-and-six-million-funerals) as a complement to this episode. Also check out their jobs page (https://jobs.popvax.com/) for opportunities.
This episode includes
- How he started PopVax and (went bankrupt in the process)
- Why there hasn't been a successful Indian mRNA vaccine yet
- Why developing countries can't afford drugs for rare diseases
- What they're doing to fix it
- Their biggest constraints
For the best experience, listen in Metacast app for iOS or Android